D
SOPHiA GENETICS SA
SOPH
$3.12
-$0.18-5.46%
D
Sell
3/11/2025Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 3/11/2025 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.2778 to -$0.23, and total revenue increased 11.86% from $15.85M to $17.73M.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 3/11/2025 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.2778 to -$0.23, and total revenue increased 11.86% from $15.85M to $17.73M.
E
Sell
2/25/2025Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 2/25/2025 due to a decline in the volatility index and valuation index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 2/25/2025 due to a decline in the volatility index and valuation index.
D
Sell
2/7/2025Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index and growth index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index and growth index.
E
Sell
1/23/2025Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index.
D
Sell
1/8/2025Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 1/8/2025 due to an increase in the volatility index, solvency index and valuation index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 1/8/2025 due to an increase in the volatility index, solvency index and valuation index.
E
Sell
10/28/2024Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 10/28/2024 due to a decline in the volatility index and total return index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 10/28/2024 due to a decline in the volatility index and total return index.
D
Sell
10/11/2024Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 10/11/2024 due to an increase in the volatility index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 10/11/2024 due to an increase in the volatility index.
E
Sell
9/23/2024Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 9/23/2024 due to a decline in the volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 9/23/2024 due to a decline in the volatility index.
D
Sell
9/6/2024Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 9/6/2024 due to an increase in the volatility index and total return index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 9/6/2024 due to an increase in the volatility index and total return index.
E
Sell
8/16/2024Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 8/16/2024 due to a decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.02 to 0.13, and earnings per share declined from -$0.2098 to -$0.2305.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 8/16/2024 due to a decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.02 to 0.13, and earnings per share declined from -$0.2098 to -$0.2305.
D
Sell
2/26/2024Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 2/26/2024 due to an increase in the volatility index and total return index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 2/26/2024 due to an increase in the volatility index and total return index.
E
Sell
2/9/2024Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 2/9/2024 due to a decline in the volatility index and growth index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 2/9/2024 due to a decline in the volatility index and growth index.
D
Sell
1/22/2024Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 1/22/2024 due to an increase in the total return index and volatility index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 1/22/2024 due to an increase in the total return index and volatility index.
E
Sell
1/4/2024Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 1/4/2024 due to a decline in the volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 1/4/2024 due to a decline in the volatility index.
D
Sell
12/13/2023Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 12/13/2023 due to an increase in the volatility index and total return index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 12/13/2023 due to an increase in the volatility index and total return index.
E
Sell
11/28/2023Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 11/28/2023 due to a decline in the total return index and volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 11/28/2023 due to a decline in the total return index and volatility index.
D
Sell
11/10/2023Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 11/10/2023 due to a noticeable increase in the growth index, volatility index and solvency index. Earnings per share increased from -$0.3317 to -$0.2124, EBIT increased 17.47% from -$20.05M to -$16.54M, and total revenue increased 8.3% from $15.05M to $16.3M.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 11/10/2023 due to a noticeable increase in the growth index, volatility index and solvency index. Earnings per share increased from -$0.3317 to -$0.2124, EBIT increased 17.47% from -$20.05M to -$16.54M, and total revenue increased 8.3% from $15.05M to $16.3M.
E
Sell
11/6/2023Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 11/6/2023 due to a decline in the volatility index, growth index and valuation index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 11/6/2023 due to a decline in the volatility index, growth index and valuation index.
D
Sell
10/16/2023Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 10/16/2023 due to an increase in the volatility index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 10/16/2023 due to an increase in the volatility index.
E
Sell
9/27/2023Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 9/27/2023 due to a decline in the total return index and volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 9/27/2023 due to a decline in the total return index and volatility index.
D
Sell
9/12/2023Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 9/12/2023 due to an increase in the volatility index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 9/12/2023 due to an increase in the volatility index.
E
Sell
8/25/2023Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 8/25/2023 due to a decline in the total return index and volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 8/25/2023 due to a decline in the total return index and volatility index.
D
Sell
8/10/2023Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 8/10/2023 due to an increase in the growth index, volatility index and solvency index. Operating cash flow increased 30.19% from -$14.79M to -$10.32M, and total revenue increased 7.79% from $13.97M to $15.05M.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 8/10/2023 due to an increase in the growth index, volatility index and solvency index. Operating cash flow increased 30.19% from -$14.79M to -$10.32M, and total revenue increased 7.79% from $13.97M to $15.05M.
E
Sell
7/28/2023Downgrade
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 7/28/2023 due to a decline in the volatility index.
SOPHiA GENETICS SA (SOPH) was downgraded to E+ from D- on 7/28/2023 due to a decline in the volatility index.
D
Sell
7/10/2023Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 7/10/2023 due to an increase in the volatility index.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 7/10/2023 due to an increase in the volatility index.
E
Sell
6/23/2023Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 6/23/2023 due to a decline in the volatility index.
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 6/23/2023 due to a decline in the volatility index.
D
Sell
6/2/2023Upgraded
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 6/2/2023 due to an increase in the volatility index and total return index.
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 6/2/2023 due to an increase in the volatility index and total return index.
E
Sell
5/17/2023Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 5/17/2023 due to a decline in the growth index, volatility index and valuation index. Operating cash flow declined 43.18% from -$10.33M to -$14.79M, earnings per share declined from -$0.2176 to -$0.3066, and EBIT declined 29.12% from -$14.94M to -$19.29M.
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 5/17/2023 due to a decline in the growth index, volatility index and valuation index. Operating cash flow declined 43.18% from -$10.33M to -$14.79M, earnings per share declined from -$0.2176 to -$0.3066, and EBIT declined 29.12% from -$14.94M to -$19.29M.
D
Sell
5/3/2023Upgraded
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 5/3/2023 due to an increase in the total return index, volatility index and growth index.
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 5/3/2023 due to an increase in the total return index, volatility index and growth index.
E
Sell
4/17/2023Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 4/17/2023 due to a decline in the volatility index.
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 4/17/2023 due to a decline in the volatility index.
D
Sell
3/30/2023Upgraded
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 3/30/2023 due to an increase in the volatility index and total return index.
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 3/30/2023 due to an increase in the volatility index and total return index.
E
Sell
3/14/2023Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index.
Sophia Genetics SA (SOPH) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index.
D
Sell
3/9/2023Upgraded
Sophia Genetics SA (SOPH) was upgraded to D from D- on 3/9/2023 due to an increase in the growth index, total return index and solvency index. Operating cash flow increased 54.74% from -$22.82M to -$10.33M, earnings per share increased from -$0.3631 to -$0.2176, and EBIT increased 36.81% from -$23.64M to -$14.94M.
Sophia Genetics SA (SOPH) was upgraded to D from D- on 3/9/2023 due to an increase in the growth index, total return index and solvency index. Operating cash flow increased 54.74% from -$22.82M to -$10.33M, earnings per share increased from -$0.3631 to -$0.2176, and EBIT increased 36.81% from -$23.64M to -$14.94M.
D
Sell
2/23/2023Upgraded
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 2/8/2023 due to a major decline in the solvency index and total return index. The quick ratio declined from 7.21 to 6.98.
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 2/8/2023 due to a major decline in the solvency index and total return index. The quick ratio declined from 7.21 to 6.98.
D
Sell
5/31/2022Upgraded
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 5/31/2022 due to an increase in the volatility index and valuation index.
Sophia Genetics SA (SOPH) was upgraded to D- from E+ on 5/31/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/13/2022Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 5/13/2022 due to a decline in the volatility index, growth index and solvency index. EBIT declined 19.39% from -$20.96M to -$25.02M, earnings per share declined from -$0.3347 to -$0.3989, and the quick ratio declined from 9.52 to 8.3.
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 5/13/2022 due to a decline in the volatility index, growth index and solvency index. EBIT declined 19.39% from -$20.96M to -$25.02M, earnings per share declined from -$0.3347 to -$0.3989, and the quick ratio declined from 9.52 to 8.3.
D
Sell
5/5/2022Upgraded
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 05/05/2022.
SOPHiA GENETICS SA (SOPH) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
Sophia Genetics SA (SOPH) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
3/22/2022Downgrade
Sophia Genetics SA (SOPH) was downgraded to D- from D on 3/22/2022 due to a large decline in the volatility index, efficiency index and total return index. Total capital declined 4.69% from $302.65M to $288.46M, and net income declined 0.62% from -$21.24M to -$21.37M.
Sophia Genetics SA (SOPH) was downgraded to D- from D on 3/22/2022 due to a large decline in the volatility index, efficiency index and total return index. Total capital declined 4.69% from $302.65M to $288.46M, and net income declined 0.62% from -$21.24M to -$21.37M.
D
Sell
10/15/2021None
SOPHiA GENETICS SA (SOPH) was downgraded to D from U on 10/15/2021.
SOPHiA GENETICS SA (SOPH) was downgraded to D from U on 10/15/2021.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
